Skip to main content
Livermore
Livermore
ZHEN

Theleme Partners LLP

SEC CIK
0001511881
Latest filing
Aug 13, 2026

The latest 13F from Theleme Partners LLP covers Q2 2026 (filed Aug 13, 2026): 9 long positions worth $1.68B. The top 10 holdings make up 100.0% of the portfolio, and the largest is Moderna, Inc. (MRNA) at 33.5%. Livermore has 25 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
2
Est. +$150.2M
Added
6
Est. +$36.1M
Reduced
0
Sold out
2
Est. −$177.8M

Top 5 holdings

Share of this quarter's portfolio value

  1. MRNAModerna, Inc.
    33.5%$564.3MHistory
  2. METAMeta Platforms, Inc.
    15.4%$258.8MHistory
  3. UBERUber Technologies, Inc
    13.7%$230.7MHistory
  4. AMZNAmazon Com Inc
    11.7%$196.1MHistory
  5. TRUTransUnion
    10.2%$171.0MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. EQIXEquinix Inc
    +$110.1MNewHistory
  2. HDBHDFC Bank Ltd
    +$40.2MNewHistory
  3. AMZNAmazon Com Inc
    +$20.7MAddedHistory
  4. EFXEquifax Inc
    +$5.26MAddedHistory
  5. METAMeta Platforms, Inc.
    +$4.72MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. EQIXEquinix Inc
    +6.54 pp0.0% → 6.5%History
  2. MRNAModerna, Inc.
    +6.28 pp27.2% → 33.5%History
  3. HDBHDFC Bank Ltd
    +2.39 pp0.0% → 2.4%History
  4. AMZNAmazon Com Inc
    +1.44 pp10.2% → 11.7%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. FLUTFlutter Entertainment plc
    −$98.5MSold outHistory
  2. HOODRobinhood Markets, Inc.
    −$79.3MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. FLUTFlutter Entertainment plc
    −6.56 pp6.6% → 0.0%History
  2. HOODRobinhood Markets, Inc.
    −5.29 pp5.3% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$1.68B
+$182.3M (+12.1%) vs. prior quarter
Positions
9
0 vs. prior quarter
Top 10 concentration
100.0%
Top 10 as share of value
Turnover
11.2%
Q2 2026, one quarter
Average holding period
11.7 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $3.50B (Q3 2021)

Q1 2021: $2.99BQ2 2021: $3.42BQ3 2021: $3.50BQ4 2021: $3.25BQ1 2022: $3.13BQ2 2022: $2.50BQ3 2022: $2.05BQ4 2022: $2.60BQ1 2023: $2.33BQ2 2023: $2.21BQ3 2023: $1.99BQ4 2023: $1.90BQ1 2024: $1.82BQ2 2024: $2.01BQ3 2024: $1.70BQ4 2024: $1.49BQ1 2025: $1.27BQ2 2025: $1.65BQ3 2025: $1.56BQ4 2025: $1.54BQ1 2026: $1.50BQ2 2026: $1.68B
Q1 2021Q2 2026
13F filings of Theleme Partners LLP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 13, 20269$1.68BMRNAMETAUBERvs. Q1 2026SEC
Q1 2026May 15, 20269$1.50BMRNAMETAUBERvs. Q4 2025SEC
Q4 2025Feb 17, 20269$1.54BMETAMRNAFLUTvs. Q3 2025SEC
Q3 2025Nov 13, 202510$1.56BMETAWFCMRNAvs. Q2 2025SEC
Q2 2025Aug 14, 202510$1.65BMRNAWFCMETAvs. Q1 2025SEC
Q1 2025May 15, 202512$1.27BMRNAAMZNWFCvs. Q4 2024SEC
Q4 2024Feb 14, 202511$1.49BMRNABACWFCvs. Q3 2024SEC
Q3 2024Nov 14, 202410$1.70BMRNASCHWTRUvs. Q2 2024SEC
Q2 2024Aug 14, 20248$2.01BMRNASCHWWFCvs. Q1 2024SEC
Q1 2024May 14, 20247$1.82BMRNASCHWWFCvs. Q4 2023SEC
Q4 2023Feb 13, 20249$1.90BMRNASCHWWFCvs. Q3 2023SEC
Q3 2023Nov 14, 202310$1.99BMRNASCHWWFCvs. Q2 2023SEC
Q2 2023Aug 14, 20239$2.21BMRNAWFCSCHWvs. Q1 2023SEC
Q1 2023May 15, 202311$2.33BMRNAWFCSCHWvs. Q4 2022SEC
Q4 2022Feb 10, 202310$2.60BMRNAWFCSCHWvs. Q3 2022SEC
Q3 2022Nov 14, 202210$2.05BMRNAWFCSCHWvs. Q2 2022SEC
Q2 2022Aug 12, 202212$2.50BMRNAWFCLRCXvs. Q1 2022SEC
Q1 2022May 13, 202211$3.13BMRNAWFCAAvs. Q4 2021SEC
Q4 2021May 26, 2022Amended9$3.25BMRNAWFCAAvs. Q3 2021SEC
Q3 2021May 26, 2022Amended7$3.50BMRNAWFCMETAvs. Q2 2021SEC
Q2 2021Aug 13, 20219$3.42BMRNAWFCTMUSvs. Q1 2021SEC
Q1 2021May 13, 202112$2.99BMRNAWFCTMUS–SEC